Profilo
Sheldon Sloan is Chief Medical Officer at Spyre Therapeutics, Inc. since 2024.
Formerly, Chief Medical Officer at Abivax SA from 2023 to 2024.
Education includes graduate degree from the University of Pennsylvania, undergraduate degree from Illinois Urbana Champaign University of, and doctorate from Rush Medical College.
Posizioni attive di Sheldon Sloan
| Società | Posizione | Inizio |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2024 |
Precedenti posizioni note di Sheldon Sloan
| Società | Posizione | Fine |
|---|---|---|
| ABIVAX | Direttore Tecnico/Scientifico/R&S | 15/07/2024 |
Formazione di Sheldon Sloan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rush Medical College
Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
















